BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 22, 2002
View Archived Issues
Bypassing Bypassing, Marrow Stem Cells Invoke Angiogenesis To Relieve Clogged Leg Arteries
Read More
Other News To Note
Read More
Quarterly Earnings Reports
Read More
Increased Scrutiny Expected In Monitoring Phase IV Studies
WASHINGTON - When a drug company asks the FDA to clear a product for marketing, the parties often agree that the company will conduct a postmarketing, or Phase IV, study. (BioWorld Today)
Read More
Focused On Tissue Repair, Collgard Names New CEO
Read More